Aaron Mendelsohn, a director of Vivani Medical, Inc., filed an amended statement of changes in beneficial ownership on November 20, 2026, correcting a transaction code error in his original November 19, 2026 filing related to a private share purchase dated November 18, 2026.

Key Highlights

  • Amendment purpose: The filing corrects an administrative error in which the original submission "inadvertently included an incorrect transaction code," replacing code "D" with the correct code "A."
  • Shares acquired: Mendelsohn purchased 99,010 shares of Vivani Medical common stock at $1.01 per share on November 18, 2026.
  • Transaction structure: The purchase was made in a private sale transaction pursuant to a Share Purchase Agreement dated November 15, 2026, with gross proceeds of $100,000.10.
  • Price reference: The $1.01 per share price was described as "the last reported sale price of the Issuer's common stock on the Nasdaq on November 13, 2026 (the trading day immediately prior to November 15, 2026)."
  • Resulting indirect ownership: Following the transaction, 997,327 shares are reported as indirectly beneficially owned by Mendelsohn.
  • Total beneficial ownership: According to the filing, Mendelsohn owns 1,165,497 shares directly and/or indirectly across personal holdings, five grandchild trusts, and MFE, LLC.

Aaron Mendelsohn's Corrected Private Purchase of Vivani Medical Shares

According to the amended filing, Aaron Mendelsohn, identified as a director of Vivani Medical, Inc. (NASDAQ:VANI), entered into a Share Purchase Agreement dated November 15, 2026, under which he acquired 99,010 shares of the company's common stock in a private sale at $1.01 per share. The filing states that the price corresponded to the last reported Nasdaq sale price on November 13, 2026, the trading day immediately preceding the agreement date. Total gross proceeds from the transaction were reported as $100,000.10.

The amendment was filed because the original November 19, 2026 submission contained what the filing describes as an administrative error: an incorrect transaction code of "D" (disposed) was used when the correct code should have been "A" (acquired). The corrected filing replaces that designation to accurately reflect the nature of the transaction as an acquisition. No other substantive details of the original transaction were changed by the amendment.

The filing further details Mendelsohn's overall beneficial ownership structure. He holds 168,170 shares directly, 150,930 shares held across five trusts established for separate grandchildren over which he has voting and dispositive authority, and 846,397 shares held by MFE, LLC, also subject to his voting and dispositive authority. However, Mendelsohn "disclaims pecuniary interest in 20% of MFE, LLC and therefore disclaims 169,279 shares" of the LLC's holdings, which the filing notes "are beneficially owned by other members of the limited liability company." Vivani Medical is a medical device company whose shares trade on the Nasdaq under the ticker VANI.

What Was Disclosed

This amended filing corrects a transaction code error from the prior day's submission and confirms that director Aaron Mendelsohn acquired 99,010 shares of Vivani Medical common stock at $1.01 per share via a private sale on November 18, 2026, resulting in total indirect beneficial ownership of 997,327 shares following the transaction.